S&S Healthcare Holding Ltd. (4198) AI Stock Analysis

S&S Healthcare Holding Ltd.

(TPEx:4198)

Select Model

Rating:46Neutral

Price Target:TWD 44.00▼(-8.33% Downside)

Action:initiatedcoverage

Date:11/10/26

Financial performance weighs most with balance sheet gains offset by weak profits and cash burn. Technical signals are mixed with short-term pressure, while negative valuation from losses caps the score.

Positive Factors

De-risked Balance SheetSharply lower leverage and substantial equity relative to assets provide a stronger financial foundation than in 2020–2022. This de-risking can improve resilience and preserve room to support operations, even though losses continue to pressure returns.

Negative Factors

Persistent Operating LossesNegative EBIT and net income in 2024–2025 show that increased revenue has not yet translated into sustainable earnings. Persistent losses weaken earnings visibility, reduce internally generated capital, and make the business more dependent on successful execution before it can support durable returns.

S&S Healthcare Holding Ltd. (4198) vs. SPDR S&P 500 ETF (SPY)

Market Cap: TWD 1.08B
Dividend Yield: ―
Average Volume (3M): 7,926
Price to Earnings (P/E): -28.1
Beta (1Y): 0.30
Revenue Growth: ―
EPS Growth: ―
Country: TW
Employees: 200
Sector: General
Sector Strength: 55
Industry: Medical - Devices

S&S Healthcare Holding Ltd. Business Overview & Revenue Model

Company Description

S&S Healthcare Holding Ltd. is dedicated to the research, manufacturing, and global commercialization of medical imaging equipment. The company's operations extend across international markets, including significant presences in Taiwan, the United St...

S&S Healthcare Holding Ltd. Financial Statement Overview

Summary

Balance sheet strengthened with sharp debt reduction and healthy leverage, but weak profitability, inconsistent revenue, and persistent negative cash flow limit the score.

Income Statement

32Negative

Balance Sheet

78Positive

Cash Flow

28Negative

Financial statement breakdown
Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	171.88M	204.21M	240.25M	275.11M	254.44M	122.35M
Gross Profit	53.22M	58.85M	75.01M	35.66M	38.39M	-7.93M
EBITDA	-28.59M	-27.02M	-17.60M	133.81M	-33.61M	-71.64M
Net Income	-40.47M	-47.30M	-41.28M	103.61M	-66.89M	-95.39M
Balance Sheet
Total Assets	353.99M	377.06M	433.83M	613.34M	531.06M	294.12M
Cash, Cash Equivalents and Short-Term Investments	73.47M	122.39M	150.02M	198.99M	112.32M	121.88M
Total Debt	25.38M	28.44M	53.32M	88.08M	183.91M	124.06M
Total Liabilities	101.62M	100.37M	116.24M	209.24M	315.64M	199.92M
Stockholders Equity	204.00M	226.50M	260.85M	300.74M	135.25M	54.99M
Cash Flow
Free Cash Flow	-39.80M	-29.12M	-71.10M	-99.25M	-142.07M	-80.36M
Operating Cash Flow	-34.83M	-26.66M	-52.04M	-68.10M	-72.91M	-70.52M
Investing Cash Flow	15.62M	12.33M	7.22M	181.95M	-82.25M	-9.25M
Financing Cash Flow	-14.14M	-33.66M	-4.56M	-29.59M	149.97M	112.47M

S&S Healthcare Holding Ltd. Peers Comparison

Overall Rating

UnderperformOutperform

Sector (55)

Financial Indicators

TW:4198 against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
TW:6242	61Neutral	TWD 1.07B	13.90	―	5.97%	-0.93%	-10.65%
Sector *	55Neutral	$6.65B	3.83	-15.92%	6.20%	10.91%	7.18%
TW:4198	46Neutral	TWD 1.10B	-28.07	―	―	―	―
TW:4109	45Neutral	TWD 1.21B	256.25	―	1.95%	13.00%	902.22%
TW:4121	42Neutral	TWD 1.01B	-25.02	―	―	0.08%	-10.61%

* General Sector Average

Performance Comparison

TW:4198 and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
TW:4198	S&S Healthcare Holding Ltd.	48.00	10.00	26.32%
TW:4109	Jia Jie Biomedical Co., Ltd.	10.25	-5.51	-34.96%
TW:4121	Rossmax International Ltd.	12.25	-3.05	-19.93%
TW:6242	LI KANG BIOMEDICAL Co. Ltd.	33.50	-3.36	-9.12%
TW:6518	Concord Medical Co Ltd	29.85	4.98	20.00%
TW:6543	Perfect Medical Industry Co., Ltd.	16.55	-10.96	-39.85%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 09, 2026

S&S Healthcare Holding Ltd. AI Stock Analysis